Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
15.63
-0.15 (-0.95%)
Jan 30, 2026, 3:04 PM CST

SHE:002007 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
4,2544,3665,3334,5034,4265,016
Other Revenue
13.5813.588.913.6710.317.09
4,2674,3795,3424,5174,4365,023
Revenue Growth (YoY)
-13.26%-18.02%18.26%1.82%-11.69%35.76%
Cost of Revenue
1,8641,7681,7271,6991,5381,405
Gross Profit
2,4042,6113,6152,8182,8983,618
Selling, General & Admin
993.771,0661,4651,2051,0111,328
Research & Development
355.91333.18280.84314.7253.63213.21
Other Operating Expenses
67.2138.3544.6241.7536.1737.29
Operating Expenses
1,4311,4321,8051,5951,3121,621
Operating Income
972.531,1791,8101,2231,5861,997
Interest Expense
-7.96-12.95-13.17-30.27-21.72-4.97
Interest & Investment Income
126.42157.95164.47128.9285.28100.8
Currency Exchange Gain (Loss)
-0.15-0.15-0.3-0.010.330.3
Other Non Operating Income (Expenses)
-12.85-0.49-0.28-0.38-0.34-0.44
EBT Excluding Unusual Items
1,0781,3231,9611,3221,6502,093
Gain (Loss) on Sale of Investments
26.6532.9460.5436.1126.8625.96
Gain (Loss) on Sale of Assets
0.520.0844.4447.670.42-0.26
Asset Writedown
6.57-5.71-9.71-1.19-3.23-0.62
Other Unusual Items
0.52-11.8121.2424.1714.3929.33
Pretax Income
1,1121,3392,0781,4281,6882,147
Income Tax Expense
140.25183.14315.96180.76234.13303.21
Earnings From Continuing Operations
972.011,1551,7621,2481,4541,844
Minority Interest in Earnings
-23.39-67.62-280.11-171.34-155.22-231.06
Net Income
948.621,0881,4821,0761,2991,613
Net Income to Common
948.621,0881,4821,0761,2991,613
Net Income Growth
-29.10%-26.57%37.66%-17.14%-19.48%25.69%
Shares Outstanding (Basic)
1,8271,8261,8241,8251,8211,818
Shares Outstanding (Diluted)
1,8271,8291,8241,8281,8311,820
Shares Change (YoY)
-0.16%0.23%-0.19%-0.17%0.59%0.13%
EPS (Basic)
0.520.600.810.590.710.89
EPS (Diluted)
0.520.590.810.590.710.89
EPS Growth
-28.98%-26.75%37.92%-17.00%-19.95%25.52%
Free Cash Flow
1,104803.92592.43563.36621.15703.85
Free Cash Flow Per Share
0.600.440.330.310.340.39
Dividend Per Share
0.7000.2000.3000.3000.2000.300
Dividend Growth
133.33%-33.33%-50.00%-33.33%-2.50%
Gross Margin
56.33%59.62%67.67%62.38%65.33%72.03%
Operating Margin
22.79%26.92%33.89%27.08%35.76%39.76%
Profit Margin
22.23%24.84%27.73%23.83%29.28%32.11%
Free Cash Flow Margin
25.87%18.36%11.09%12.47%14.00%14.01%
EBITDA
1,2331,4392,0691,4961,7832,179
EBITDA Margin
28.90%32.86%38.74%33.12%40.18%43.38%
D&A For EBITDA
260.84260.07259.05272.5196.39181.66
EBIT
972.531,1791,8101,2231,5861,997
EBIT Margin
22.79%26.92%33.89%27.08%35.76%39.76%
Effective Tax Rate
12.61%13.68%15.21%12.65%13.87%14.12%
Revenue as Reported
4,2674,3795,3424,5174,4365,023
Advertising Expenses
-5.086.312.843.382.58
Source: S&P Global Market Intelligence. Standard template. Financial Sources.